Therapy using polymersome technology restores BBB transport function rather than acting on the neurons or other brain cells.

Leukemia cells evade immune attack via SLAMF6, and by blocking this protein with a new antibody, researchers restored T cell function in AML.

Newly discovered diversity in the wheat genome could offer new opportunities to improve and ‘climate-proof’ one of the world’s most important staple crops.

Company researchers unveil LEGION, designed to search chemical space around targets, then protect discoveries from fast patenting by rivals.

A major challenge in AAV gene therapy has been developing scalable, cost-efficient processes to reliably produce high-quality vectors.

This year's prize recognized what the committee described as fundamental discoveries that launched the field of peripheral immune tolerance.

Chronic stress disrupts O-glycans in the mouse prefrontal cortex. The findings open new possibilities for depression treatment.

The Global Biopharma Index provides companies with the insights needed to bring the next generation of medicines to clinic.

By stepping out as the first biopharma to win a three-year exemption from President Donald Trump’s earlier-announced plans for 100% tariffs, in return for agreeing to manufacture more of its drugs in ...

Universities must do more to provide students with cell and gene therapy manufacturing skills, according to a new study.

Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster the ...

The breakthrough was made possible with the help of specialized enzymes designed to address blood-type incompatibility in transplants.